Phage φC31 integrase-mediated site-specific integration for gene therapy

Gene Therapy and Regulation

Volumn 2, Issue 2, 2004, Pages 103-120

  Olivares, Eric C ^a   Calos, Michele P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidermolysis bullosa; Gene therapy; Hemophilia; Phage integrase; Recombinase; Site specific integration

Indexed keywords

ALPHA 1 ANTITRYPSIN; BLOOD CLOTTING FACTOR 9; COLLAGEN TYPE 7; INTEGRASE; LAMININ; LAMININ B3; PLASMID DNA; RECOMBINASE; UNCLASSIFIED DRUG;

BACTERIOPHAGE; BINDING SITE; CATALYSIS; DNA INTEGRATION; DNA RECOMBINATION; EPIDERMOLYSIS BULLOSA; GENE SEQUENCE; GENE THERAPY; GENETIC DISORDER; GENOME; HEMOPHILIA; HUMAN; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NONHUMAN; REVIEW; STREPTOMYCES;

EUKARYOTA; STREPTOMYCES;

EID: 1342345175     PISSN: 13889532     EISSN: None     Source Type: Journal    
DOI: 10.1163/156855803322664600     Document Type: Review

References (68)

1. Abremski, K. and Hoess, R. (1984). Bacteriophage P1 site-specific recombination, purification and properties of the cre recombinase protein. J. Biol. Chem., 259: 1509-1514.
2. Andrews, B.J., Proteau, G.A., Beatty, L.G. and Sadowski, P.D. (1985). The flp recombinase of the 2 micron circle DNA of yeast: Interaction with its target sequences. Cell, 40: 795-803.
3. Belteki, G., Gertsenstein, M., Ow, D.W. and Nagy, A. (2003). Site-specific cassette exchange and germline transmission with mouse es cells expressing φC31 integrase. Nat. Biotechnol., 21: 321-324.
4. Bushman, F.D. (2002). Integration site selection by lentiviruses: Biology and possible control. Curr. Top. Microbiol. Immunol., 261: 165-177.
5. Capecchi, M. (1989). The new mouse genetics: altering the genome by gene targeting. Trends Genet., 5: 70-76.
6. Chen, S.J., Tazelaar, J., Moscioni, A.D. and Wilson, J.M. (2000). In vivo selection of hepatocytes transduced with adeno-associated viral vectors. Mol. Ther., 1: 414-422.
7. Chen, Z.Y., Yant, S.R., He, C.Y., Meuse, L., Shen, S. and Kay, M.A. (2001). Linear dnas concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol. Ther., 3: 403-410.
8. Combes, P., Till, R., Bee, S. and Smith, M.C. (2002). The streptomyces genome contains multiple pseudo-attB sites for the φC31-encoded site-specific recombination system. J. Bacteriol., 184: 5746-5752.
9. Craig, N.L. and Nash, H.A. (1983). The mechanism of phage lambda site-specific recombination: Site-specific breakage of DNA by int topoisomerase. Cell, 35: 795-803.
10. Craig, N.L. and Nash, H.A. (1984). E. Coli integration host factor binds to specific sites in DNA. Cell, 39: 707-716.
11. Dupuy, A.J., Fritz, S. and Largaespada, D.A. (2001). Transposition and gene disruption in the male germline of the mouse. Genesis, 30: 82-88.
12. Dupuy, A.J., Clark, K., Carlson, C.M., Fritz, S., Davidson, A.E., Markley, K.M., Finley, K., Fletcher, C.F., Ekker, S.C., Hackett, P.B., Horn, S. and Largaespada, D.A. (2002). Mammalian germ-line transgenesis by transposition. Proc. Natl. Acad. Sci. USA, 99: 4495-4499.
13. Engelman, A. (1994). Most of the avian genome appears available for retroviral DNA integration. Bioessays, 16: 797-799.
14. Fischer, S.E., Wienholds, E. and Plasterk, R.H. (2001). Regulated transposition of a fish transposon in the mouse germ line. Proc. Natl. Acad. Sci. USA, 98: 6759-6764.
15. Gill, D.R., Smyth, S.E., Goddard, C.A., Pringle, I.A., Higgins, C.F., Colledge, W.H. and Hyde, S.C. (2001). Increased persistence of lung gene expression using plasmids containing the ubiquitin c or elongation factor 1α promoter. Gene Ther., 8: 1539-1546.
16. Grompe, M., Al-Dhalimy, M., Finegold, M., Ou, C.N., Burlingame, T., Kennaway, N.G. and Soriano, P. (1993). Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Devel., 7: 2298-2307.
17. Grompe, M., Lindstedt, S., al-Dhalimy, M., Kennaway, N.G., Papaconstantinou, J., Torres-Ramos, C.A., Ou, C.N. and Finegold, M. (1995). Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type 1. Nat. Genet., 10: 453-460.
18. Groth, A.C., Olivares, E.C., Thyagarajan, B. and Calos, M.P. (2000). A phage integrase directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. USA, 97: 5995-6000.
19. Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.P., Thrasher, A.J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., Fischer, A., Davies, E.G., Kuis, W., Leiva, L. and Cavazzana-Calvo, M. (2002). Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med., 346: 1185-1193.
20. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.L., Fraser, C.C., Cavazzana-Calvo, M. and Fischer, A. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med., 348: 255-256.
21. Herweijer, H. and Wolff, J.A. (2003). Progress and prospects: Naked DNA gene transfer and therapy. Gene Ther., 10: 453-458.
22. Ivics, Z., Hackett, P.B., Plasterk, R.H. and Izsvak, Z. (1997). Molecular reconstruction of sleeping beauty, a tc1-like transposon from fish, and its transposition in human cells. Cell, 91: 501-510.
23. Kaiser, J. (2003). Gene therapy. Seeking the cause of induced leukemias in x-scid trial. Science, 299: 495.
24. Karsi, A., Moav, B., Hackett, P. and Liu, Z. (2001). Effects of insert size on transposition efficiency of the sleeping beauty transposon in mouse cells. Mar. Biotechnol., 3: 241-245.
25. Kay, M., Rothenberg, S., Landen, C.N., Bellinger, D.A., Leland, F., Toman, C., Finegold, M., Thompson, A.R., Read, M.S., Brinkhous, K.M. and Woo, S.L.C. (1993). In vivo gene therapy of hemophilia b: Sustained partial correction in factor ix-deficient dogs. Science, 262: 117-119.
26. Kearns, W.G., Afione, S.A., Fulmer, S.B., Pang, M.C., Erikson, D., Egan, M., Landrum, M.J., Flotte, T.R. and Cutting G.R. (1996). Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther., 3: 748-755.
27. Kootstra, N.A. and Verma, I.M. (2003). Gene therapy with viral vectors. Annu. Rev. Pharmacol. Toxicol., 43: 413-439.
28. Kuhstoss, S. and Rao, R.N. (1991). Analysis of the integration function of the streptomycete bacteriophage φC31. J. Mol. Biol., 222: 897-908.
29. Kvittingen, E.A., Rootwelt, H., Berger, R. and Brandtzaeg, P. (1994). Self-induced correction of the genetic defect in tyrosinemia type I. J. Clin. Invest., 94: 1657-1661.
30. Landy, A. (1989). Dynamic, structural, and regulatory aspects of lambda site-specific recombination. Annu. Rev. Biochem., 58: 913-949.
31. Liu, F., Song, Y.K. and Liu D. (1999). Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy, 6: 1258-1266.
32. Luo, G., Ivics, Z., Izsvak, Z. and Bradley, A. (1998). Chromosomal transposition of a tc1/mariner-like element in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA, 95: 10769-10773.
33. Malinda, K.M. and Kleinman, H.K. (1996). The laminins. Int. J. Biochem. Cell. Biol., 28: 957-959.
34. Manning, K., Al-Dhalimy, M., Finegold, M. and Grompe, M. (1999). In vivo suppressor mutations correct a murine model of hereditary tyrosinemia type i. Proc. Natl. Acad. Sci. USA, 96: 11928-11933.
35. Marshall, E. (2003). Gene therapy. Second child in french trial is found to have leukemia. Science, 299: 320.
36. Miao, C.H., Ohashi, K., Patijn, G.A., Meuse, L., Ye, X., Thompson, A.R. and Kay, M.A. (2000). Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor ix gene expression in vivo but not in vitro. Mol. Ther., 1: 522-532.
37. Miller, D.G., Rutledge, E.A. and Russell, D.W. (2002). Chromosomal effects of adeno-associated virus vector integration. Nat. Genet., 30: 147-148.
38. Montini, E., Held, P.K., Noll, M., Morcinek, N., Al-Dhalimy, M., Finegold, M., Yant, S.R., Kay, M.A. and Grompe, M. (2002). In vivo correction of murine tyrosinemia type i by DNA-mediated transposition. Mol. Ther., 6: 759-769.
39. Olivares, E.C., Hollis, R.P. and Calos M.P. (2001). Phage R4 integrase mediates efficient integration in mammalian cells. Gene, 278: 167-176.
40. Olivares, E.C., Hollis, R.P., Chalberg, T.W., Meuse, L., Kay, M.A. and Calos, M.P. (2002). Site-specific genomic integration produces therapeutic factor ix levels in mice. Nat. Biotechnol., 20: 1124-1128.
41. Ortiz-Urda, S., Thyagarajan, B., Keene, D.R., Lin, Q., Fang, M., Calos, M.P. and Khavari, P.A. (2002). Stable nonviral genetic correction of inherited human skin disease. Nat. Med., 8: 1166-1170.
42. Ortiz-Urda, S., Lin, Q., Green, C.L., Keene, D.R., Marinkovich, M.P. and Khavari, P.A. (2003a). Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J. Clin. Invest., 111: 251-255.
43. Ortiz-Urda, S., Thyagarajan, B., Keene, D.R., Lin, Q., Calos, M.P. and Khavari, P.A. (2003b). φC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum. Gene Ther., in press.
44. Overturf, K., Al-Dhalimy, M., Tanguay, R., Brantly, M., Ou, C.N., Finegold, M. and Grompe, M. (1996). Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type 1. Nat. Genet., 12: 266-273.
45. Overturf, K., Al-Dhalimy, M., Manning, K., Ou, C.N., Finegold, M. and Grompe, M. (1998). Ex vivo hepatic gene therapy of a mouse model of hereditary tyrosinemia type 1. Hum. Gene Ther., 9: 295-304.
46. Pfeifer, A. and Verma, I.M. (2001). Gene therapy: Promises and problems. Annu. Rev. Genomics Hum. Genet., 2: 177-211.
47. Rabbitts, T.H., Bucher, K., Chung, G., Grutz, G., Warren, A. and Yamada, Y. (1999). The effect of chromosomal translocations in acute leukemias: The lmo2 paradigm in transcription and development. Cancer Res., 59: 1794s-1798s.
48. Robbins, P.B., Lin, Q., Goodnough, J.B., Tian, H., Chen, X. and Khavari, P.A. (2001). In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa. Proc. Natl. Acad. Sci. USA, 98: 5193-5198.
49. Sadowski, P. (1986). Site-specific recombinases: Changing partners and doing the twist. J. Bacteriol., 165: 341-347.
50. Sarkis, G.J., Murley, L.L., Leschziner, A.E., Boocock, M.R., Stark, W.M., Grindley, N.D. (2001). A model for the gamma delta resolvase synaptic complex. Mol. Cell., 8: 623-631.
51. Sauer, B. (1992). Identification of cryptic lox sites in the yeast genome by seletion for cre-mediated chromosome translocations that confer multiple drug resistance. J. Mol. Biol., 223: 911-928.
52. Sauer, B. and Henderson, N. (1988). Site-specific DNA recombination in mammalian cells by the cre recombinase of bacteriophage p1. Proc. Natl. Acad. Sci. USA, 85: 5166-5170.
53. Schroder, A.R., Shinn, P., Chen, H., Berry, C., Ecker, J.R. and Bushman, F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110: 521-529.
54. Sclimenti, C.R., Thyagarajan, B. and Calos, M.P. (2001). Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res., 29: 5044-5051.
55. Smith, M.C., Burns, R.N., Wilson, S.E. and Gregory, M.A. (1999). The complete genome sequence of the streptomyces temperate phage Cφ31: Evolutionary relationships to other viruses. Nucleic Acids Res., 27: 2145-2155.
56. Smith, M.C. and Thorpe, H.M. (2002). Diversity in the serine recombinases. Mol. Microbiol., 44: 299-307.
57. Stoll, S.M., Ginsburg, D.S. and Calos, M.P. (2002). Phage tp901-1 site-specific integrase functions in human cells. J. Bacteriol., 184: 3657-3663.
58. Surosky, R.T., Urabe, M., Godwin, S.G., McQuiston, S.A., Kurtzman, G.J., Ozawa, K. and Natsoulis, G. (1997). Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol., 71: 7951-7959.
59. Thomason, L.C., Calendar, R. and Ow, D.W. (2001). Gene insertion and replacement in schizosaccharomyces pombe mediated by the streptomyces bacteriophage φC31 site-specific recombination system. Mol. Genet. Genomics, 265: 1031-1038.
60. Thorpe, H.M. and Smith, M.C.M. (1998). In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc. Natl. Acad. Sci. USA, 95: 5505-5510.
61. Thorpe, H.M., Wilson, S.E. and Smith, M.C. (2000). Control of directionality in the site-specific recombination system of the streptomyces phage φC31. Mol. Microbiol., 38: 232-241.
62. Thyagarajan, B., Guimaraes, M.J., Groth, A.C. and Calos, M.P. (2000). Mammalian genomes contain active recombinase recognition sites. Gene, 244: 47-54.
63. Thyagarajan, B., Olivares, E.C., Hollis, R.P., Ginsburg, D.S. and Calos, M.P. (2001). Site-specific genomic integration in mammalian cells mediated by phage φC31 integrase. Mol. Cell. Biol., 21: 3926-3934.
64. Vigdal, T.J., Kaufman, C.D., Izsvak, Z., Voytas, D.F. and Ivics, Z. (2002). Common physical properties of DNA affecting target site selection of sleeping beauty and other tc1/mariner transposable elements. J. Mol. Biol., 323: 441-452.
65. Withers-Ward, E.S., Kitamura, Y., Barnes, J.P. and Coffin, J.M. (1994). Distribution of targets for avian retrovirus DNA integration in vivo. Genes Dev., 8: 1473-1487.
66. Yanez, R.J. and Porter, A.C. (1998). Therapeutic gene targeting. Gene Ther., 5: 149-159.
67. Yant, S., Meuse, L., Chiu, W., Ivics, Z., Izsvak, Z. and Kay, M.A. (2000). Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet., 25: 35-41.
68. Zhang, G., Song, Y.K. and Liu, D. (2000). Long-term expression of human alpha-1-antitrypsin gene in mouse liver achieved by intravenous adminstration of plasmid DNA using a hydrodynamics-based procedure. Gene Ther., 7: 1344-1349.